Cangrelor is an intravenous P2Y12 platelet inhibitor used to prevent thrombotic events in patients undergoing percutaneous coronary intervention (PCI). It provides rapid and reversible platelet inhibition, making it valuable in acute settings. Unlike oral antiplatelets, it acts almost immediately and is quickly cleared. Bleeding is the primary risk associated with its use.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Cangrelor and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Cangrelor impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Cangrelor-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
